Résultats de la recherche - Michael T. Nurmohamed
- Résultat(s) 1 - 20 résultats de 70
- Aller à la page suivante
-
1
-
2
-
3
-
4
-
5
Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study par Alper M. van Sijl, Maarten Boers, Alexandre E. Voskuyl, Michael T. Nurmohamed
Publié 2014Artigo -
6
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment par Ernest Choy, Kandeepan Ganeshalingam, Anne Grete Semb, Zoltán Szekanecz, Michael T. Nurmohamed
Publié 2014Revisão -
7
-
8
Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis par Michael T. Nurmohamed, Yanjun Bao, James Signorovitch, Alex Trahey, Parvez Mulani, Diana Dan
Publié 2015Artigo -
9
-
10
-
11
-
12
(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosi... par Debby den Uyl, Michael T. Nurmohamed, L. van Tuyl, Hennie G. Raterman, Willem F. Lems
Publié 2011Revisão -
13
-
14
Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial par M. l’Ami, C. Krieckaert, Michael T. Nurmohamed, Ronald van Vollenhoven, Theo Rispens, Maarten Boers, Gertjan Wolbink
Publié 2017Artigo -
15
Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review par Daisy Vedder, Wendy Walrabenstein, Maaike Heslinga, Ralph de Vries, Michael T. Nurmohamed, Dirkjan van Schaardenburg, Martijn Gerritsen
Publié 2019Revisão -
16
-
17
Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care par Markus M. J. Nielen, Alper M. van Sijl, Mike J. Peters, Robert Verheij, François Schellevis, Michael T. Nurmohamed
Publié 2012Artigo -
18
Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. par Vokko P. van Halm, Michael T. Nurmohamed, Jos W. R. Twisk, Ben A. C. Dijkmans, Alexandre E. Voskuyl
Publié 2006Artigo -
19
Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis par J. Christiaan van Denderen, I.M. Visman, Michael T. Nurmohamed, Maria S.A. Suttorp-Schulten, Irene van der Horst‐Bruinsma
Publié 2014Artigo -
20
Residual disease activity in psoriatic arthritis: discordance between the rheumatologist’s opinion and minimal disease activity measurement par Leonieke van Mens, M. Turina, M. G. H. Van de Sande, Michael T. Nurmohamed, Arno W. R. van Kuijk, Dominique Baeten
Publié 2017Artigo
Outils de recherche:
Sujets similaires
Medicine
Internal medicine
Rheumatoid arthritis
Disease
Immunology
Physical therapy
Adalimumab
Arthritis
Environmental health
Gastroenterology
Ankylosing spondylitis
Population
Cohort
Rheumatology
Endocrinology
Intensive care medicine
Antibody
Pathology
Psoriatic arthritis
Spondylitis
Tumor necrosis factor alpha
Cohort study
Inflammation
Prospective cohort study
Risk factor
Surgery
Alternative medicine
Coronavirus disease 2019 (COVID-19)
Etanercept
Infectious disease (medical specialty)